Vaccines, Blood & Biologics

2018 Biological License Application Supplement Noteworthy Approvals

This list reflects information regarding the supplements as of the approval date. It is not updated with regard to applicant or application status changes. The supplements are listed by date of approval, with the most recent action at the top.

2018 Biological License Application Supplement Noteworthy Approvals
Tradename/Proper NameIndication for UseSTNManufacturer/
License No.
Approval Date
FLUARIX ® Quadrivalent
Influenza Virus Vaccine
To extend the age range for use of Fluarix Quadrivalent to include children 6 to 35 months of age.125127/834GlaxoSmithKline Biologicals
Rue de l'Institut 89,
B1330 Rixensart, Belgium

Lic. # 1617
1/11/2018

 

Page Last Updated: 02/13/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English